Daniel J. Burdick
Impact in
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
Papers in
-
- Chemical Synthesis and Analysis 5
- RNA and protein synthesis mechanisms 4
-
- Cell Adhesion Molecules Research 5
- Co-authors
- John P. Burnier (5 shared papers)Thomas R. Gadek (5 shared papers)Charles W. Eigenbrot (3 shared papers)Peter L. Barker (3 shared papers)James A. Wells (2 shared papers)Paul M. Carter (1 shared paper)Sherron L. Bullens (2 shared papers)Robert S. McDowell (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (9 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)ACS Medicinal Chemistry Letters (3 papers)ACS Chemical Biology (2 papers)Peptides (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Daniel J. Burdick
40 papers receiving 1.8k citations
Daniel J. Burdick's Hit Papers
Peers
Comparison fields: 5 of 93
- Neurology 550
- Immunology and Allergy 162
- Molecular Biology 1.0k
- Hematology 151
- Organic Chemistry 291
Countries citing papers authored by Daniel J. Burdick
This map shows the geographic impact of Daniel J. Burdick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Burdick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Burdick more than expected).
Fields of papers citing papers by Daniel J. Burdick
This network shows the impact of papers produced by Daniel J. Burdick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Burdick. The network helps show where Daniel J. Burdick may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel J. Burdick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 309 | |
| 2 | 1992 | 148 | |
| 3 | 2002 | 147 | |
| 4 | 2012 | 140 | |
| 5 | 2013 | 113 | |
| 6 | Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2023 | 108 |
| 7 | 2016 | 102 | |
| 8 | 1989 | 93 | |
| 9 | 2012 | 76 | |
| 10 | 1995 | 63 | |
| 11 | 2017 | 61 | |
| 12 | 2014 | 54 | |
| 13 | 2015 | 48 | |
| 14 | 1994 | 44 | |
| 15 | 2012 | 43 | |
| 16 | 1994 | 42 | |
| 17 | 2011 | 34 | |
| 18 | 2016 | 30 | |
| 19 | 2015 | 29 | |
| 20 | 1993 | 26 |
About Daniel J. Burdick
Daniel J. Burdick is a scholar working on Molecular Biology, Immunology and Allergy, Oncology, Pharmacology and Hematology, having authored 41 papers that have together received 1.9k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (7 papers), Computational Drug Discovery Methods (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Chemical Synthesis and Analysis (5 papers), Cell Adhesion Molecules Research (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and RNA and protein synthesis mechanisms (4 papers). The work is most often cited by research in Neurology (550 citations), Immunology and Allergy (162 citations), Molecular Biology (1.0k citations), Hematology (151 citations) and Organic Chemistry (291 citations). Daniel J. Burdick has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include John P. Burnier, Thomas R. Gadek, Charles W. Eigenbrot, Peter L. Barker, James A. Wells, Paul M. Carter, Sherron L. Bullens, Robert S. McDowell, Stuart Bunting and Robin D. Gantzos. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, ACS Chemical Biology and Peptides.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.